Laura Sepp-Lorenzino, Ph.D. Executive Vice President, Chief Scientific Officer Laura Sepp-Lorenzino oversees all platform and pipeline research activities across in vivoMeaning “within the living”, this type of therapy is administered directly into the patient, targeting the cells and editing the genome from inside the body. and ex vivoAlso referred to as a cell therapy. In … Continue reading Laura Sepp-Lorenzino, Ph.D.